Evidence map›Paper›PMID 27790250›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2016

Cytotoxic activity of

Louisa Béchohra, Fatima Laraba-Djebari, Djelila Hammoudi-Triki

Open access · goldAbstract read
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. The journal of venomous animals and toxins including tropical diseases · 2025
    Article
  4. Article
  5. Article
  6. The Evaluation ofJournal of arthropod-borne diseases · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Louisa BéchohraUSTHB, Faculty of Biological Sciences, Laboratory of cellular and Molecular Biology, BP32, El Alia, Bab Ezzouar, 16111 Algiers, Algeria.
Fatima Laraba-DjebariUSTHB, Faculty of Biological Sciences, Laboratory of cellular and Molecular Biology, BP32, El Alia, Bab Ezzouar, 16111 Algiers, Algeria.
Djelila Hammoudi-TrikiUSTHB, Faculty of Biological Sciences, Laboratory of cellular and Molecular Biology, BP32, El Alia, Bab Ezzouar, 16111 Algiers, Algeria.
University of Algiers Benyoucef Benkhedda · DZUniversity of Sciences and Technology Houari Boumediene · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have showed that animal venoms are a source of bioactive compounds that may inhibit the growth of cancer cells, which makes them useful agents for therapeutic applications. Recently, it was established that venom toxins from scorpions induced cytotoxic, antiproliferative and apoptogenic effects on cancer cells. Therefore, the present study aims to investigate the cytotoxic activity of

methodsThe cytotoxic and antiproliferative activities were estimated using MTT assay, lactate dehydrogenase release and clonogenic assays. Apoptosis was evaluated by Hoechst 33258 staining, DNA fragmentation assay and caspase-3 activity. Oxidative stress was analyzed by reactive oxygen species, nitric oxide, malondialdehyde and protein carbonyl levels along with assessment of antioxidant status. In addition, alteration of mitochondrial membrane potential was analyzed by JC1 fluorescent dye.

resultsThe present findings showed that F3 fraction was more cytotoxic towards NCI-H358 lung cancer cells with an IC

conclusionThese findings suggest that F3 fraction could induce apoptosis in lung cancer cells through involvement of oxidative stress and mitochondrial dysfunction. Hence, these properties make F3 fraction a promising candidate for development of new anticancer agents.

Indexed as

Aah venomApoptosiscytotoxicityF3 fractionLung cancer cellsOxidative stress

Identifiers

PMID27790250
PMCPMC5075196
OpenAlexW2539142795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.